Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Pudao Pharmaceutical Technology is a specialized pharmaceutical research and development company based in Changsha, China, focusing on high-end complex drug delivery systems. The company has established advanced technology platforms for the development of long-acting microspheres, liposomes, nanocrystals, and inhalation preparations. Pudao provides comprehensive CRO and CDMO services, supporting global pharmaceutical partners from early-stage formulation research through to clinical trial material production and industrial scale-up. Their therapeutic focus primarily includes central nervous system disorders, oncology, and metabolic diseases, where they leverage sustained-release technologies to improve patient compliance and therapeutic efficacy. The firm operates a state-of-the-art GMP-compliant facility designed to meet the rigorous manufacturing standards required for complex injectable products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Pudao Pharmaceutical Technology.